Show an ad over header. AMP

COVAX vaccine initiative involves most of the world, but U.S. or China

Data: Gavi, The Vaccine Alliance; Map: Naema Ahmed/Axios

A global initiative to ensure equitable distribution of coronavirus vaccines now includes most of the world — but not the U.S., China or Russia.

Why it matters: Assuming one or more vaccines ultimately gain approval, there will be a period of months or even years in which supply lags far behind global demand. The COVAX initiative is an attempt to ensure doses go where they're most needed, rather than simply to countries that can produce or buy them at scale.


How it works: COVAX — led by the WHO, the Coalition for Epidemic Preparedness Innovations and the Gavi vaccine alliance — is investing in the production of nine vaccines, including candidates from the U.S., Europe and China. It plans to distribute any that are approved to all participating countries.

  • The funding will come from wealthier countries and other donors, with poorer countries receiving subsidized access.

A draft plan envisions a first phase of proportional distribution across all countries until about 20% of their populations are vaccinated.

  • The guidelines suggest health workers be vaccinated first, followed by the elderly and those with serious health conditions (countries will make their own allocation decisions).
  • In a second wave of more widespread distribution, each country’s "COVID threat and vulnerability" will be taken into account.

Where things stand: 65 higher-income economies have now joined the 92 that are eligible for subsidized access. Together, they comprise 64% of the global population.

  • A further 35 higher-income countries or territories have said they intend to join.

The other side: The U.S. is independently buying up doses of six vaccine candidates and has said it won't participate in COVAX, citing the influence of "the corrupt World Health Organization and China."

  • China isn't currently part of COVAX. It may still join, but it plans to give its citizens and some friendly countries priority access to any vaccine it produces.
  • Russia hasn't joined either. Like China, it says it will make its vaccine available to other countries, but it wants to control that process.
  • President Trump, meanwhile, has said the U.S. will vaccinate Americans first and then share any remaining doses.

Between the lines: COVAX will be competing for a scarce supply of vaccines with both the U.S. and some of its own participants.

  • The U.K., Japan and EU plan to participate in COVAX, but they have also been purchasing tens of millions of doses for their own populations.
  • Meanwhile, India is eligible for access under COVAX, but it has also been promised some 500 million doses by the Serum Institute of India, the world's highest-capacity vaccine manufacturer.

What to watch: The groups behind COVAX argue that its diversified "portfolio" of vaccines gives countries their best shot at obtaining access to one that works.

  • Russia, by contrast, appears to be putting all of its hopes into a single vaccine, called Sputnik.
  • The White House says it's confident that at least one of the six vaccines the U.S. has invested in will work.
  • The latest: Johnson & Johnson's vaccine became the fourth to begin phase 3 trials in the U.S. this week.

The bottom line: We're sprinting toward a potential vaccine, and there's now a plan in place to distribute it around the world. But this is one of the most complex global undertakings in decades, and success is far from guaranteed.

Go deeper: Where the vaccine race stands in the U.S.

Apps are helping people of color stop deadly police encounters

Mobile phone apps are evolving in ways that can stop rather than simply document deadly police encounters with people of color — including notifying family and lawyers about potential violations in real time.

Why it matters: As states and cities face pressure to reform excessive force policies, apps that monitor police are becoming more interactive, gathering evidence against rogue officers as well as posting social media videos to shame the agencies.

Keep reading... Show less

TikTok gets more time (again)

The White House is again giving TikTok's Chinese parent company more time to satisfy its national security concerns, rather than initiating legal action, a source familiar with the situation tells Axios.

The state of play: China's ByteDance had until Friday to satisfy national security concerns raised by the Committee on Foreign Investment in the U.S. (CFIUS), which is chaired by Treasury secretary Steve Mnuchin. This was the company's third deadline, with CFIUS having provided two earlier extensions.

Keep reading... Show less

Federal judge orders Trump administration to restore DACA

A federal judge on Friday ordered the Trump administration to fully restore the Deferred Action for Childhood Arrivals program, giving undocumented immigrants who arrived in the U.S. as children a chance to petition for protection from deportation.

Why it matters: DACA was implemented under former President Obama, but President Trump has sought to undo the program since taking office. Friday’s ruling will require Department of Homeland Security officers to begin accepting applications starting Monday and guarantee that work permits are valid for two years.

Keep reading... Show less

Bay Area counties to enact stay-at-home order

Counties around the San Francisco Bay Area will adopt California’s new regional stay-at-home order amid surges in cases and ICU hospitalizations, health officials said Friday.

The big picture: California Gov. Gavin Newsom announced a three-week stay-at-home order on Thursday that would go into effect in regions with less than 15% ICU capacity. Despite the Bay Area’s current 25.3% ICU capacity, health officials from Alameda, Contra Costa, Marin, Santa Clara, San Francisco and the city of Berkeley are moving ahead with a shelter-in-place mandate in the hopes of reducing risk.

Keep reading... Show less

Podcast: Former FDA chief Rob Califf on the COVID-19 vaccine approval process

The U.S. Food and Drug Administration (FDA) is reviewing two emergency use authorization requests for COVID-19 vaccines, with an outside advisory committee scheduled to meet next Thursday to review data from Pfizer and its German partner BioNTech.

Axios Re:Cap digs in with former FDA commissioner Rob Calif about the EUA process, the science and who should make the final call.

The U.S. economic recovery needs rocket fuel

Data: BLS. Chart: Axios Visuals

Friday's deeply disappointing jobs report should light a fire under Congress, which has dithered despite signs the economy is struggling to kick back into gear.

Driving the news: President-elect Biden said Friday afternoon in Wilmington that he supports another round of $1,200 checks.

Keep reading... Show less

CDC: It's time for "universal face mask use"

The CDC is urging “universal face mask use” for the first time since the coronavirus pandemic began, citing recent case spikes as the U.S. has entered a phase of “high-level transmission” before winter officially begins.

Why it matters: Daily COVID-related deaths across the U.S. hit a new record on Wednesday. Face coverings have been shown to increase protection of the wearer and those around them, despite some Americans' reluctance to use them.

Keep reading... Show less

Saudi Arabia and Qatar near deal to end standoff, sources say

Saudi Arabia and Qatar are close to a deal to end the diplomatic crisis in the Gulf following U.S.-mediated reconciliation talks this week, sources familiar with the talks tell me.

Why it matters: Restoring relations between Saudi Arabia and Qatar would bring a sense of stability back to the Gulf after a 3.5 year standoff. It could also notch a last-minute achievement for the Trump administration before Jan. 20.

Keep reading... Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories